ONCY >>I suspect that in the next 1-4 months, we will get the results from the first part of phase III (aprox 80-100 patients) and it will be hugely successful.<<
Considering all the oncolytic viruses which were cleverly engineered to be extremely selective to cancer cells, some of which also were given an additional killing or immune-activating gene - all of which failed or were given up on ... the chance that a non-engineered, naturally occuring virus will succeed is next to nil (IMO).
The real question is how many more years ONCY can drag things out before being forced to admit failure. Doubt they can beat Introgen's record.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.